Research Participation in Substance Use Disorder Trials: Design and Methods of a Multi-Site Nested Qualitative Study
Foreman-Mackey A, Pauly B, Ivsins A, Urbanoski K, Mansoor M, Bardwell G, Subst Abuse Treat Prev Policy, 2022.
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial
Socias ME, Wood E, Le Foll B, Lim R, Choi JC, Mok WY, Bruneau J, Rehm J, Wild TC, Bozinoff N, Hassan A, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. Addiction. 2022
Challenges and opportunities for further research involving the cannabis-to-opioid use transition
Bahji A, Milloy MJ, Bach P, Sociás ME. Addiction. 2022
What are the best practices for psychotherapy with Indigenous peoples in the United States and Canada? A thorny question
Wendt D.C., Huson K., Albatnuni M., Gone J.P., Journal of Consulting and Clinical Psychology, 2022
Harm reduction in the hospital: An overdose prevention site (OPS) at a Canadian hospital
Nolan S, Kelian S, Kerr T, Young S, Malmgren I, Ghafari C, Harrison S, Wood E, Lysyshyn M, Holliday E., Alcohol Depend. 2022
Challenges and opportunities for further research involving the cannabis-to-opioid use transition
Bahji A, Milloy MJ, Bach P, Sociás ME., Addiction. 2022
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial
Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Bruneau J, Fischer B, Rehm J, Wild TC, Wood E, Brissette S, Gagnon L, Fikowski J, Ledjiar O, Masse B, Socias ME; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse., Am J Psychiatry. 2022
Crack cocaine use frequency is associated with HIV disease severity independent of antiretroviral therapy exposure: a prospective cohort study
Macmadu A, Reddon H, Marshall BDL, Fairbairn N, Nolan S, Socías ME, Milloy MJ., AIDS Behav. 2022
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial
Socias ME, Wood E, Le Foll B, Lim R, Choi JC, Mok WY, Bruneau J, Rehm J, Wild TC, Bozinoff N, Hassan A, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse.,
Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada
Ivsins A, MacKinnon L, Bowles JM, Slaunwhite A, Bardwell G., J Urban Health. 2022
